News
ATR
140.49
+1.41%
1.95
5 Dividend Aristocrats Where Analysts See Capital Gains
NASDAQ · 21h ago
AptarGroup (NYSE:ATR) sheds 12% this week, as yearly returns fall more in line with earnings growth
Simply Wall St · 2d ago
SEE's Q2 Earnings Beat Estimates, Sales Dip Y/Y on Lower Volumes
NASDAQ · 2d ago
Ball Corp Earnings Surpass Estimates in Q2, Sales Increase Y/Y
NASDAQ · 2d ago
AptarGroup: Strong Performance and Growth Potential Amid Temporary Challenges
TipRanks · 3d ago
AptarGroup Is Maintained at Overweight by Wells Fargo
Dow Jones · 3d ago
AptarGroup Price Target Cut to $153.00/Share From $173.00 by Wells Fargo
Dow Jones · 3d ago
Wells Fargo Maintains Overweight on AptarGroup, Lowers Price Target to $153
Benzinga · 3d ago
AptarGroup Is Maintained at Outperform by Raymond James
Dow Jones · 3d ago
AptarGroup Price Target Cut to $172.00/Share From $182.00 by Raymond James
Dow Jones · 3d ago
Raymond James Maintains Outperform on AptarGroup, Lowers Price Target to $172
Benzinga · 3d ago
AptarGroup price target lowered to $172 from $182 at Raymond James
TipRanks · 4d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), Avantor (AVTR) and AptarGroup (ATR)
TipRanks · 4d ago
Weekly Report: what happened at ATR last week (0728-0801)?
Weekly Report · 4d ago
AptarGroup Reports Strong Q2 2025 Results
TipRanks · 6d ago
AptarGroup Earnings Call: Pharma and Closures Shine
TipRanks · 6d ago
AptarGroup (ATR) Q2 Revenue Rises 6%
NASDAQ · 6d ago
AptarGroup expects Q3 adjusted EPS of $1.53–$1.61 while navigating inventory headwinds and litigation costs
Seeking Alpha · 6d ago
AptarGroup Down Over 9%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk
Dow Jones · 6d ago
AptarGroup beats top-line and bottom-line estimates; initiates Q3 outlook
Seeking Alpha · 08/01 08:05
More
Webull provides a variety of real-time ATR stock news. You can receive the latest news about Aptargroup through multiple platforms. This information may help you make smarter investment decisions.
About ATR
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. It operates in three segments. The Aptar Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions and services for the prescription drug, consumer health care, injectables, active material science solutions and digital health market. It also specializes in nasal drug delivery for delivering drugs. The Aptar Beauty segment sells dispensing systems and sealing solutions for the beauty, personal care and home care markets. The Aptar Closures segment sells dispensing systems, sealing solutions and food service trays to the food, beverage, personal care, home care, beauty and healthcare markets. This segment also includes the food protection business and the elastomeric flow-control technology business.